Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Quarterly Results

Quarterly Results

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE811.10-10.9 (-1.33 %)
PREV CLOSE ( ) 822.00
OPEN PRICE ( ) 821.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10085
TODAY'S LOW / HIGH ( )805.50 835.90
52 WK LOW / HIGH ( ) 635904
Quarters
GO
Select year  
( in Million)
Particulars
Mar 2025
Audited / UnAudited
UnAudited
Net Sales
1674.08
Total Expenditure
1501.56
PBIDT (Excl OI)
172.52
Other Income
NA
Operating Profit
172.51
Interest
81.47
Exceptional Items
NA
PBDT
91.04
Depreciation
18.4
Profit Before Tax
72.64
Tax
12.61
Provisions and contingencies
NA
Profit After Tax
60.03
Extraordinary Items
NA
Prior Period Expenses
NA
Other Adjustments
NA
Net Profit
60.03
Minority Interest
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
Consolidated Net Profit
60.04
Equity Capital
47.22
Face Value (IN RS)
10
Reserves
NA
Calculated EPS
12.71
Calculated EPS (Annualised)
50.85
No of Public Share Holdings
2411277
% of Public Share Holdings
51.07
 
NA
PBIDTM% (Excl OI)
10.30
PBIDTM%
10.30
PBDTM%
5.43
PBTM%
4.33
PATM%
3.58
 
Notes
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
To Close Account, Please Click Here
For Nomination, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.